Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma × catumaxomab × 1 year × Clear all

Sponsor

Interventions

pembrolizumab 22 Cisplatin 22 Magnetic Resonance Spectroscopy 14 Carboplatin 14 Specimen Handling 13 Paclitaxel 13 durvalumab 10 Pemetrexed 10 Nivolumab 8 Radiotherapy, Intensity-Modulated 7 Platinum 7 1,2-diaminocyclohexaneplatinum II citrate 7 Docetaxel 6 Cetuximab 6 Biopsy 6 Gemcitabine 5 Cyclophosphamide 5 osimertinib 4 cemiplimab 4 cabozantinib 4 Taxes 4 Radiotherapy 4 Radiation 4 Oxaliplatin 4 Ipilimumab 4 Fluorouracil 4 1-(1-(imidazo(1,2-a)pyridin-6-yl)ethyl)-6-(1-methyl-1H-pyrazol-4-yl)-1H-(1,2,3)triazolo(4,5-b)pyrazine 4 (225)Ac-DOTA-c(RGDyK) 4 poly ICLC 3 fludarabine phosphate 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡